Assessment of the Frequency and Contributing Factors for Major Infectious Diseases in UK Migrants: A Systematic Review
-
By
-
Rebecca F. Baggaley
-
Carys M. Hooper
-
Luisa Silva
-
Zainab Lal
-
Paul Bird
-
Dee Menezes
-
Dominik Zenner
-
Christopher A. Martin
-
Manish Pareek
-
March 3, 2026
-
Clinical Scorecard: Assessment of the Frequency and Contributing Factors for Major Infectious Diseases in UK Migrants: A Systematic Review
At a Glance
| Category | Detail |
|---|
| Condition | Communicable diseases in migrants (TB, HIV, HBV, HCV) |
| Key Mechanisms | Increased exposure, substandard living conditions, limited healthcare access |
| Target Population | Migrants to the UK |
| Care Setting | Primary care and public health settings |
Key Highlights
- 82% of TB notifications in 2024 were in migrants
- Higher HIV prevalence in migrants compared to native populations
- 95% of new chronic hepatitis B diagnoses in migrants
- Increased risk of late presentation and aggressive disease progression
- Importance of early diagnosis and management to reduce morbidity and mortality
Guideline-Based Recommendations
Diagnosis
- Screen migrants for active and latent TB
- Screen for HIV, hepatitis B, and hepatitis C
Management
- Integrated approach to testing and treatment for migrants
Monitoring & Follow-up
- Track prevalence of infections in migrant populations for effective health planning
Risks
- Increased risk of reactivation of latent TB due to migration stressors
Patient & Prescribing Data
Migrants residing in the UK
Targeted testing strategies based on risk factors for infections
Clinical Best Practices
- Implement routine screening for TB, HIV, HBV, and HCV in migrant populations
- Utilize a risk-based approach for targeted testing
- Ensure access to healthcare for migrants to facilitate early diagnosis
References
